1. Home
  2. PWP vs ANIP Comparison

PWP vs ANIP Comparison

Compare PWP & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWP
  • ANIP
  • Stock Information
  • Founded
  • PWP 2006
  • ANIP 2001
  • Country
  • PWP United States
  • ANIP United States
  • Employees
  • PWP N/A
  • ANIP N/A
  • Industry
  • PWP Finance: Consumer Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWP Finance
  • ANIP Health Care
  • Exchange
  • PWP Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • PWP 1.3B
  • ANIP 1.4B
  • IPO Year
  • PWP N/A
  • ANIP N/A
  • Fundamental
  • Price
  • PWP $20.56
  • ANIP $67.48
  • Analyst Decision
  • PWP Hold
  • ANIP Strong Buy
  • Analyst Count
  • PWP 3
  • ANIP 9
  • Target Price
  • PWP $23.33
  • ANIP $80.56
  • AVG Volume (30 Days)
  • PWP 1.2M
  • ANIP 288.7K
  • Earning Date
  • PWP 08-01-2025
  • ANIP 08-05-2025
  • Dividend Yield
  • PWP 1.36%
  • ANIP N/A
  • EPS Growth
  • PWP N/A
  • ANIP N/A
  • EPS
  • PWP N/A
  • ANIP N/A
  • Revenue
  • PWP $987,743,000.00
  • ANIP $674,068,000.00
  • Revenue This Year
  • PWP $5.01
  • ANIP $30.84
  • Revenue Next Year
  • PWP $19.08
  • ANIP $7.39
  • P/E Ratio
  • PWP N/A
  • ANIP N/A
  • Revenue Growth
  • PWP 59.48
  • ANIP 30.27
  • 52 Week Low
  • PWP $14.12
  • ANIP $52.50
  • 52 Week High
  • PWP $27.03
  • ANIP $77.00
  • Technical
  • Relative Strength Index (RSI)
  • PWP 59.24
  • ANIP 58.60
  • Support Level
  • PWP $18.92
  • ANIP $64.27
  • Resistance Level
  • PWP $21.52
  • ANIP $68.20
  • Average True Range (ATR)
  • PWP 0.71
  • ANIP 2.04
  • MACD
  • PWP 0.03
  • ANIP 0.09
  • Stochastic Oscillator
  • PWP 63.08
  • ANIP 77.60

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: